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Introduction
Ion exchange chromatography (IEX) is a common chemical separation technique used to
separate ionizable target molecules from a mixture by adsorption of the target molecule to a
resin. A typical ion exchange resin consists of microscopic spherical beads that are coated with a
binding ligand that is positively or negatively charged. The ion exchange chromatography
process can be divided into four broad categories: strong cation exchange, strong anion
exchange, weak cation exchange, and weak anion exchange. Cation exchange involves a
negatively charged stationary phase (affinity for cations), whereas anion exchange involves a
positively charged stationary phase (affinity for anions) [8]. In chromatography, the stationary
phase is the porous solid that the target molecule and mobile phase flows through, and is
commonly referred to as resin or beads. The mobile phase is the liquid solvent which flows
through the stationary phase. The target molecule is solvated in the mobile phase and is captured
onto the stationary phase while remaining fractions flow through and are discarded. Strong IEX
resins are named so because they display the same amount of charge over the entire pH range of
possible mobile phases used. While pH resins can vary by distributor, the range is typically 1-14.
Weak IEX resins tend to optimally operate over a smaller pH range [12]. This is often a direct
result of the binding ligand the resin utilizes. In part, the strength of charge of the binding ligand
is used to determine the separation protocol for the target analyte. Strong cation exchange resins
typically have analogs of sulfonate groups (-CH2CH2CH2SO32-) as the binding ligand, and strong
anion exchangers typically have analogs of quaternary ammonium groups (-N+(CH3)3). Weak
cation exchange resins typically use analogs of carboxymethyl groups (-OCH2COO-) and weak
anion exchangers tend to use analogs diethylaminoethyl groups (-N+H(CH2CH3)2) [10]. While
these functional groups are generally the most common for each respective class of ion
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exchange, vendors slightly modify the basic chemistries of their resins. Furthermore, many resin
chemistries are proprietary to the vendor and thus their intricate chemical structures are not
common knowledge. Important volumes used in IEX chromatography are bed volume (BV) and
column volume (CV). The bed volume is the volume of the resin inside the column, while the
column volume is the volume of the column including the resin bed. The void volume is the
difference between the resin bed and the column volume.
The ability of IEX to separate target analytes depends on the chemical composition of the
stationary phase and the mobile phase, as well as the properties of the target analyte.
Comparative studies of commercial ion exchange resins on the basis of their chemical properties
[9,14,15] have been reported. In IEX, the resin (stationary phase) is commonly packed into a
hollow cylindrical column, over which the liquid buffer mobile phase flows. Proper mobile
phase selection is required to equilibrate the resin to the appropriate pH. The target analyte is
then added to the column and should adsorb onto the beads, allowing impurities with less affinity
to flow through the column. Wash buffer is used to wash the resin of potential adsorbed
impurities without causing elution of the target analyte. Elution buffer liberates the target
molecule from the resin. Eluate, the fluid exiting the column upon elution, can be collected and
analyzed for presence of analyte of interest. The process of wash and elution of the analyte is
accomplished through a salt gradient and/or pH gradient. In a salt gradient, elution buffers
contain cation or anions that compete with the analyte for resin ligand binding sites. As the
concentration of ions in the buffer increase, the analyte is eluted from the column for collection.
In a pH gradient, buffers of different pH flow through the column to protonate or deprotonate the
resin and analyte, in order to elute the analyte. IEX has many practical purposes, including water
softening, separation of organic molecules from a mixture; purification of biological molecules

OPTIMIZATION OF CATION EXCHANGE

4

such as proteins, amino acids, and nucleic acids; as well as other applications [6,9,11,13]. Of
particular interest to many biotechnology companies is the purification of proteins from
mixtures. IEX may be used at benchtop scale to industrial scale production of biomolecules.
Vestaron Corporation is an industrial biotechnology company that specializes in the
development of insecticidal peptides for use in the agricultural industry. The peptides developed
are toxic to target crop pests but non-toxic to non-target organisms. VST-6700 is a proprietary
peptide being developed as the next potential insecticide active ingredient. Vestaron’s current
production strategy includes fermentation to produce the peptide, filtration to remove cells, then
concentration or purification depending upon the application. IEX is useful for purification due
to the ability to scale-up the process from small benchtop to production-scale fermentation.
Strategies for ion exchange chromatography scale up have been published, in which
mathematical models and experimental data is utilized [16]. The resin that Vestaron currently
uses to separate peptides is no longer in large-scale production, and therefore must be replaced
with a more modern commercially available resin. The resin to be replaced is SP Sephadex C-25,
from GE Healthcare. SP Sephadex C-25 is a strong cation exchange resin with sulphopropyl
ligands and a dry particle size of >40µm in diameter [5]. Cation exchange chromatography is the
recommended IEX method for the purification of VST-6700 because the isoelectric point (pI) of
the peptide is ~7 and thus VST-6700 tends to be positively charged after fermentation at pH
~4.5.
The purpose of the current study was to evaluate, optimize, and compare commercial
cation exchange resins of different chemical and physical properties for the small-scale
purification of VST-6700 from cell-free fermentation beer. Flow rates, process time, peptide
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retention, and recovery were analyzed for the resins tested by HPLC. The optimal resin chosen
must balance total process time, peptide retention, and elution efficacy.

Materials and Methods
Resin Selection
Cation IEX is the optimal purification method based on the pI of the VST-6700 molecule.
The current IEX resin in use is SP Sephadex C-25 which is a strong cation exchanger. Four
cation exchange resins were researched, optimized, and evaluated. Resins tested included: SP
Sephadex C-25 (GE Healthcare); Capto S (GE Healthcare); Nuvia HR-S (Bio-Rad); and MacroPrep CM (Bio-Rad). Capto S is a rigid strong cation exchange resin with a median particle size
of ~90µm diameter, with a sulfonate (–SO3-) binding ligand [4]. Nuvia HR-S is a strong cation
exchange resin with a median particle size of 50 ± 10µm diameter and a sulfonate (–SO3-)
binding ligand. [2]. Macro-Prep CM is a weak cation exchange resin with a median particle size
of 50µm and a (–COO-) binding ligand [1].

Resin Preparation
Capto S, Nuvia HR-S, and Macro-Prep CM resins were received as slurries. Slurries were
gently shaken and stirred until a consistent solution was achieved, then loaded on the column. SP
Sephadex C-25 was received as a powder and was reconstituted by suspending 7g of powder in
30mM sodium acetate (NaOAc), pH 4.5 equilibration buffer for 24hr and allowing the beads to
swell. The solution was then gently mixed and loaded on the column.
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Buffer Preparation
In order to optimize resins, multiple buffers at various concentrations & pH’s were used.
Buffers used in a given trial for a resin were based off previous trials of that resin. Buffers that
were successful in a previous trial were kept for further trials and buffers that were unsuccessful
in a certain IEX step were changed in subsequent trials. Changes included pH, NaCl
concentration, and/or buffer reagent type. In the case of a preliminary trial for a resin, previous
IEX protocols used by other Vestaron researchers were used. This is especially the case in Capto
S trial 1. The buffers used in IEX purification of VST-6700 using SP Sephadex C-25 are listed in
Table 1. All buffers were titrated to desired pH with 5M HCl or 5M NaOH using a pH meter
(Thermo Scientific OrionStar A211). No buffer solutions prepared precipitated during titration.
All buffers were filter-sterilized through 0.2µm PES vacuum filtration units into 250mL or
500mL bottles for storage at ambient temperature. Solutions provided by Vestaron were stored in
glass media bottles.
Table 1: Buffers used for IEX purification of VST-6700 using SP Sephadex C-25 strong cation exchange media.
SP Sephadex C-25 Buffers
Wash Buffer(s)
30mM NaOAc pH 4.5

Trial
1

Equilibration Buffer
30mM NaOAc pH 4.5

2

30mM sodium citrate pH 3.0

30mM sodium citrate pH 3.0

3
4
5
6
7
8
9-1
9-2
10

30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0

30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0
30mM sodium citrate pH 3.0

Elution Buffer(s)
30mM NaOAc pH 5.0 + 300mM NaCl
30mM NaOAc pH 5.0 + 450mM NaCl
30mM NaOAc pH 5.5 + 500mM NaCl
50mM Tris-HCl, pH 8.0
50mM Tris-HCl, pH 8.0
50mM Tris-HCl, pH 8.0
50mM Tris-HCl, pH 8 + 50mM NaCl
50mM Tris-HCl, pH 8 + 100mM NaCl
50mM Tris-HCl, pH 8 + 100mM NaCl
50mM Tris-HCl, pH 8 + 100mM NaCl
50mM Tris-HCl, pH 8 + 100mM NaCl
100% Acetonitrile
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The buffers used in the IEX purification of VST-6700 using Capto S are listed in Table
2.
Table 2: Buffers used in the optimization of IEX purification of VST-6700 from a 2mL Capto S resin bed
Capto S Buffers
Wash Buffer(s)
30mM MES pH 6

Trial

Equilibration Buffer

1

30mM NaOAc pH 4.5

Elution Buffer(s)

30mM MES pH 6 + 200mM NaCl
30mM MES pH 6 + 100mM NaCl
2
30mM NaOAc pH 4.08
30mM MES pH 6
30mM MES pH 6 + 100mM NaCl
3
30mM NaOAc pH 4.5
30mM MES pH 6
30mM MES pH 6 + 200mM NaCl
4
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5 + 200mM NaCl
5
30mM NaOAc pH 4.5
30mM MES pH 6
30mM MES pH 6 + 200mM NaCl
30mM NaOAc pH 4.5
6
30mM NaOAc pH 4.5
NA
+ 100, 200,350, 500mM NaCl
7
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5 + 400mM NaCl
8
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5 + 400mM NaCl
9
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5 + 400mM NaCl
10
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5 + 400mM NaCl
11
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5
30mM NaOAc pH 5.0 + 300mM NaCl
12
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5 + 400mM NaCl
13
30mM sodium citrate pH 3
30mM Sodium Citrate, pH 3
30mM NaOAc, pH 5 + 300mM NaCl
14
30mM sodium citrate pH 3
30mM Sodium Citrate, pH 3
30mM Tris-HCl, pH 8.8
Multiple wash buffers of increasing NaCl concentration were used in Capto S trial 6 (see Results)

The buffers used in the IEX purification of VST-6700 with Nuvia HR-S strong cation
exchange resin are listed in Table 3.
Table 3: Buffers used in the optimization of the purification of VST-6700 from a 2mL Nuvia HR-S strong cation exchange resin.

Trial
1
2
3
4

Equilibration Buffer
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5

Nuvia HR-S Buffers
Wash Buffer
30mM NaOAc pH 4.5
30mM NaOAc pH 4.5 + 50mM NaCl
30mM NaOAc pH 4.5 + 50mM NaCl
30mM NaOAc pH 4.5 + 100mM NaCl

5

30mM NaOAc pH 4.5

30mM NaOAc pH 4.5 + 50mM NaCl

6
7
8

30mM NaOAc pH 4.5
30mM sodium citrate, pH 3
30mM sodium citrate, pH 3

30mM NaOAc pH 4.5 + 50mM NaCl
30mM sodium citrate pH 3 + 50mM NaCl
30mM sodium citrate, pH 3 + 50mM NaCl

Elution Buffer
30mM NaOAc, pH 4.5 + 400mM NaCl
30mM NaOAc, pH 5.0 + 450mM NaCl
30mM NaOAc, pH 5.0 + 450mM NaCl
30mM NaOAc, pH 5.0 + 400mM NaCl
30mM NaOAc, pH 5.0 + 200mM NaCl
30mM NaOAc, pH 5.0 + 300mM NaCl
30mM NaOAc, pH 5.0 + 300mM NaCl
30mM NaOAc, pH 5.0 + 300mM NaCl
30mM Tris HCl pH 8.8

The buffers used in IEX purification of VST-6700 with Macro-Prep CM weak cation
exchange resin are listed in Table 4
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Table 4: Buffers used in the Ion Exchange purification of VST-6700 on a Macro-Prep CM weak cation exchange column.

Trial
1
2
3
4

Equilibration Buffer
30mM Sodium Citrate, pH
3.0
30mM Sodium Citrate, pH
3.0
30mM HEPES, pH 7
30mM HEPES, pH 7

Macro-Prep CM Buffers
Wash Buffer
Elution Buffer
30mM Sodium Citrate, pH
30mM Tris-HCl pH 8.8
3.0
30mM Sodium Citrate, pH
30mM Tris-HCl pH 8.8
3.0
30mM HEPES, pH 7
30mM HEPES, pH 7 + 500mM NaCl
30mM HEPES, pH 7
30mM HEPES, pH ~ VST-6700 pI + 500mM
NaCl

Note that the pH elution buffer in Trial 4 is reported as an approximate due to the proprietary nature of the peptide.

Test Material Preparation
Starting materials were small aliquots of cell free fermentation beer. Aliquots were
titrated with 5M HCl or 5M NaOH as needed with a pH meter or checked with pH paper
(Hydrion). In the event of matrix precipitation of the beer nearing pH 3 and 7 (SP Sephadex C-25
Trial 2, Macro Prep CM Trial 3), the aliquot was centrifuged at 10500rpm for 10min (Eppendorf
Centrifuge 5810R). The supernatant was then transferred to a syringe (BD) and filtered through a
series of 1.2µm, 0.45µm, and 0.2µm polyethersulfone (PES) syringe filters (AcroPrep), and
collected into a 50mL or 15mL conical tube, depending on aliquot size.
The starting materials used in the IEX purification of VST-6700 with SP
Sephadex C-25 strong cation exchange resin are listed in Table 5. The starting materials used in
the IEX purification of VST-6700 using Capto S are listed in Table 6. The starting materials
used in the IEX purification of VST-6700 using Nuvia HR-S are listed in Table 7. The starting
materials used in the IEX purification of VST-6700 using Macro-Prep CM are listed in Table 8.
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Table 5: Concentrations, titrated pH values, and batch numbers of VST-6700 cell-free beer starting material used in SPSephadex C-25 columns.

VST-6700 Starting Material
SP Sephadex C-25
Trial Peptide Conc. (mg/mL) pH
Batch
1
2.18
2.18
19-099
2
2.33
3
19-099
3
2.23
3
19-099
4
2.4
3
19-099
5
2.4
3
19-099
6
2.4
3
19-099
7
2.4
3
19-099
8
2.28
3
19-099
9.1
10
4.8 UGA 6700
9.2
10
3
UGA 6700
10
10
3
UGA 6700
Table 6: Concentrations, titrated pH values, and batch numbers of VST-6700 cell-free beer starting material used in Capto S
columns

VST-6700 Starting Material
Capto S
Trial Peptide Conc. (mg/mL) pH
1
0.125
3.6
2
2.226
4.11
3
1.971
4.25
4
1.861
4.5
5
1.903
4.5
6
1.65
4.5
7
NR
NR
8
0.612
4.5
9
0.627
4.5
10
3.793
4.5
11
3.793
4.5
12
2.23
4.5
13
3.3
3
14
3.3
3
NR = Not Recorded
.

Batch
NR
19-063
19-063
19-063
19-063
NR
NR
NR
NR
19-099
19-099
19-099
19-163
19-163
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Table 7: Concentrations, titrated pH values, and batch numbers of VST-6700 cell-free beer starting material used in Capto S
columns.

VST-6700 Starting Material
Nuvia HR-S
Trial Peptide Conc. (mg/mL) pH Batch
1
3.780
4.5
NR
2
2.39
4.5
NR
3
3.26
4.5
NR
4
2.42
4.5
NR
5
2.42
4.5
NR
6
2.42
4.5
NR
7
2.56
3 19-163
8
2.56
3 19-163
NR = Not Recorded

Table 8: Concentrations, titrated pH values, and batch numbers of VST-6700 cell-free beer starting material used in Capto S
columns.

VST-6700 Starting Material
Macro-Prep CM
Trial Peptide Conc. (mg/mL) pH
1
2.801
3
2
2.936
3
3
2.993
7
4
2.661
7
NR = Not Recorded

Batch
19-163
19-163
19-163
19-163
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IEX Column

Figure 1: Typical IEX benchtop setup. Pictured from left to right: MES wash and elution buffer, Econo-Pac column and
microcentrifuge tubes, Nuvia HR-S resin, Macro-Prep CM resin, Capto S resin, powerpipetter. Econo-Pac columns were used for
all resin trials.

Resins were packed into disposable plastic Bio-Rad Econo-Pac® Chromatography
columns (Fig. 1). The column was fitted with a 3-way stopcock to control flow rates and capped
to prevent evaporation or contamination. Resin slurries were transferred to the column via
serological pipette with a powerpipetter. All columns had 2mL resin loaded. Columns were
equilibrated with at least 6 bed volumes of equilibration buffer. Equilibration buffer was
transferred via serological pipette and deposited directly on top of the resin bed, being sure to not
disturb the bed. The stopcock was then opened to allow maximum flow rate and equilibration.
Flowthrough was discarded. Once equilibrated, the desired volume of cell-free beer containing a
known amount of VST-6700 was loaded on the resin bed in a similar manner to equilibration
buffer. Load volumes varied depending upon amount of peptide to be loaded. Peptide
concentration in starting material and column fractions were determined by HPLC analysis of the
beer (see Sample Processing and Mass Balance). The mobile phase was allowed to flow via
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gravity through the resin bed, with the flow rate being controlled as necessitated by each trial.
The maximum flow rate varied for each resin and was by gravity. The maximum flow rate by
gravity was achieved by fully opening the three-way stopcock on the column (see “Flow Rates”
under Results). The volume of equilibration buffer trapped in the resin bed (the void volume)
was collected in one fraction, and fractions of VST-6700 flowthrough were collected (Fig. 2).
The void volume was calculated using the following formula [10]:

𝑉𝑣𝑜𝑖𝑑 =

0.5𝐿𝑑𝑐2
1000

𝐿 = 𝑐𝑜𝑙𝑢𝑚𝑛 𝑙𝑒𝑛𝑔𝑡ℎ
𝑑𝑐 = 𝑐𝑜𝑙𝑢𝑚𝑛 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟
Once all analyte finished flowing through the resin bed, wash buffer was loaded on top of
the resin bed, and the stopcock opened to allow gravity flow. The void volume of peptide and
subsequent wash fractions were collected. Based off previous Vestaron research, the volume of
wash buffer required was at least 4 column volumes (CV). Once wash buffer stopped flowing
through the resin bed, elution buffer was loaded on the resin bed and fractions of eluate collected
in a similar manner. Flow rate was controlled with the stopcock as necessitated by the parameters
of each trial. Peptide concentration in each fraction was determined by HPLC, and mass balance
was performed for each trial. Any changes to the volume of wash or elution buffer needed was
determined. The fractions of peptide load, wash and elution were collected in 0.65mL, 1.7mL, or
2mL microcentrifuge tubes (VWR) (Fig. 2). Fractions were collected in 15mL centrifuge tubes
for larger fractions. Flow rates, when timed, were timed with a VWR stopwatch. Most trials were
conducted in this manner, some exceptions are noted below.
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Figure 2: Diagram showing void volume collection procedure.

Observations of the color of the column and column fractions were used in determining
the volume of mobile phase used in the column run. Clean resin beds were a white or grey color,
and this color was not altered during equilibration. During the peptide load, the column and
flowthrough fractions would change color from clear to amber. During the wash phase, collected
column fractions would change color from amber to clear, due to impurities being removed from
the column. A successful elution with adequate elution buffer resulted in a color change of the
column from brown back to white or grey. Furthermore, elution fractions collected would change
color from clear to a deep amber color. Fractions then would change from amber to clear once all
analyte was liberated from the column. Fractions were then checked for peptide concentration
via HPLC, and mass balance was performed.
The peptide load in SP Sephadex C-25 Trial 8 was different than the above procedure
(See SP Sephadex C-25 Results). After an initial peptide load, small masses of VST-6700 were
sequentially loaded and collected from the column in order to determine the maximum binding
capacity of the resin bed.
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Capto S trial 6, Capto S Trial 10, and Capto S Trial 12 differ from the above procedure.
In Capto S Trial 6, several buffers of 30mM NaOAc pH 4.5 were flown through the column,
with different NaCl concentrations in order to determine an adequate NaCl concentration
necessary to elute VST-6700 from the Capto S column (see Capto S Results). Two resin bed
volumes (4mL) of each buffer was passed through the column in increasing NaCl concentration
order. The first and last fraction of each buffer was analyzed for peptide to roughly determine the
optimal concentration of NaCl to use in an elution buffer.
Capto S Trial 10 and Trial 12 are replicates. In these trials, multiple column runs were
performed, one after the other, in order to get a set of triplicate data for peptide load loss
consistency. In Capto S Trial 10, peptide was loaded, washed, and eluted four times successively
on one resin bed. In Trial 12, three column runs were performed.

Sample Processing and Analysis
When the column trial was completed, samples of eluate fractions were filtered either
through 0.2µm Pall Nanosep spin filter inserts or Pall AcroPrep 96 well filter plates. Nanosep
filters were centrifuged at 15000rpm for 30 sec (Eppendorf Centrifuge 5424). 96 well plates
were centrifuged at 800rpm for 3min (Eppendorf Centrifuge 5810R). All HPLC samples were
prepared in a 2mL glass Phenomenex Verex vial with rubber septa cap. Aliquots of each filtered
sample were diluted either 10x or 5x with 0.15µg/µL caffeine solution. For example: in a 10x
dilution, 50µL sample was added to 450µL caffeine internal standard. For a 10x dilution and a
100µL aliquot was added to 400µL caffeine standard for a 5x dilution. In all HPLC samples,
caffeine concentration was 0.15µg/µL. Caffeine internal standards were prepared by adding
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7.5mL of 1mg/mL caffeine stock to 37.5mL of DI water. An Agilent 1100 Series HPLC and/or a
Thermo Fischer Ultimate 3000 UHPLC were used. Twenty microliter injections were made onto
a Chromolith Performance RP-18e 100-4.6mm column at ambient temperature. A gradient
method was used to elute caffeine and peptide. The method is listed in Table 9. Typical retention
time of caffeine standard was ~2min and typical retention time of VST-6700 was ~7min.
Chromeleon Software was used to visualize chromatograms. Microsoft Excel was used to
calculate peptide concentrations and perform mass balances. Data recorded included retention
time, and peak areas, peak height, injection volume, of VST-6700 and caffeine for each
injection.
Table 9: The method used in the program for Agilent 1100 HPLC and Thermo Ultimate 3000 UHPLC.

HPLC Method
Time [min] H2O + 0.1% TFA [%] Acetonitrile [%] Flow [mL/min]
0.00
90.0
10.0
2.000
1.00
90.0
10.0
2.000
4.00
77.0
23.0
2.000
9.00
63.0
37.0
2.000
9.10
0.0
100.0
2.500
12.00
0.0
100.0
2.500
12.10
90.0
10.0
2.500
14.00
90.0
10.0
2.500
Solvent A is 0.1% TFA in H20 and Solvent B is 100% ACN.

Determination of Peptide Concentration Using Internal Standard
The mass of VST-6700 in µg for a single 20µL HPLC injection was determined using
Beer’s Law by the following formula:
𝜀𝑐𝑎𝑓𝑓𝑒𝑖𝑛𝑒 × 𝑀𝑀𝑉𝑆𝑇−6700
𝐴𝑉𝑆𝑇−6700
𝑚𝑉𝑆𝑇−6700 = (
)×(
) × 𝑚𝑐𝑎𝑓𝑓𝑒𝑖𝑛𝑒 𝑖𝑛𝑗𝑒𝑐𝑡𝑒𝑑
𝜀𝑉𝑆𝑇−6700 × 𝑀𝑀𝑐𝑎𝑓𝑓𝑒𝑖𝑛𝑒
𝐴𝑐𝑎𝑓𝑓𝑒𝑖𝑛𝑒
𝑚 = 𝑚𝑎𝑠𝑠 (µg)
𝑀𝑀 = 𝑚𝑜𝑙𝑎𝑟 𝑚𝑎𝑠𝑠 (𝑔. 𝑚𝑜𝑙 −1 )

OPTIMIZATION OF CATION EXCHANGE

16

𝐴 = 𝑝𝑒𝑎𝑘 𝑎𝑟𝑒𝑎 (𝑚𝐴𝑈. 𝑠𝑒𝑐)
ɛ = 𝑚𝑜𝑙𝑎𝑟 𝑒𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 (𝐿. 𝑚𝑜𝑙 −1 . 𝑐𝑚−1)
Previous research by another Vestaron researcher shows that:

(

𝜀𝑐𝑎𝑓𝑓𝑒𝑖𝑛𝑒 × 𝑀𝑀𝑉𝑆𝑇−6700
) = 1.39492
𝜀𝑉𝑆𝑇−6700 × 𝑀𝑀𝑐𝑎𝑓𝑓𝑒𝑖𝑛𝑒

Thus, the equation was simplified to:

𝑚𝑉𝑆𝑇−6700 = (1.39492) × (

𝐴𝑉𝑆𝑇−6700
) × 𝑚𝑐𝑎𝑓𝑓𝑒𝑖𝑛𝑒
𝐴𝑐𝑎𝑓𝑓𝑒𝑖𝑛𝑒

The numerical constant 1.39492 was obtained previously and used for this study. This
constant was multiplied by the ratio of the area of VST-6700 and caffeine (in mAU.sec), which
was then multiplied by 3µg, the mass of internal standard that was present in each 20µL HPLC
injection.
Mass Balance
Once the sample concentration was known, the total amount of peptide in each column
fraction was calculated by multiplying the concentration of VST-6700 in that fraction by the
volume of that fraction. Mass (mg) of VST-6700 lost and retained in each step (load, wash,
elution) was calculated by summation of VST-6700 mass in each fraction for each individual
step. Mass balances were expressed as percentages. The percent of VST-6700 lost in the load
and wash was calculated by dividing the total mass of VST-6700 lost in each step by the total
mass of VST-6700 loaded on the column. Mass recoveries were expressed as percentages and
were calculated by dividing the total mass of VST-6700 in eluate fractions by the mass of VST6700 retained on the resin bed after the wash step.
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Results
SP Sephadex C-25
In trial 1 the column was equilibrated with 6 BV 30mM NaOAc pH 4.5. Wash buffer was
30mM NaOAc pH 4.5, and 4.25 BV were used. Elution buffer for trial 1 was 30mM NaOAc pH
4.5 + 300mM NaCl. These buffers were selected based on results from Capto S trial 8 and Nuvia
HR-S trial 6 because these resins had minimal peptide losses in the load steps and recoveries of
above 90% of retained peptide in the elution steps. All flow rates in trial 1 were the maximum
flow rate allowed by gravity, which was ≥ 3mL/min. Flow rates were also based of Capto S trial
8 and Nuvia HR-S trial 6. A VST-6700 load loss of approximately 42% (Table 11) was
observed. A loss of zero peptide in the wash was assumed because 30mM NaOAc pH 4.5
resulted in no loss of VST-6700 in Capto S trial 8. Loss of VST-6700 in the wash step was also
assumed zero for trials 4, 5, and 8. Six BV elution buffer achieved an 82% recovery of retained
peptide. The high loss of VST-6700 in the load step in trial 1 indicated that a change of pH was
necessary to allow better analyte binding to the column. Furthermore, the peptide recovery in
trial 1 suggested that an elution buffer with higher NaCl concentration may result in a higher
peptide recovery.
In order to achieve a higher binding capacity of VST-6700 on the SP Sephadex resin bed
in trial 2, the column was equilibrated with 6 BV of 30mM sodium citrate pH 3.0. 30mM sodium
citrate pH 3 equilibration buffer was used for the remainder of the trials for SP Sephadex C-25.
The wash buffer was also changed to 30mM sodium citrate pH 3.0 in order to maintain a pH of 3
on the column while washing off impurities. This wash buffer was also used for the remainder of
SP Sephadex C-25 trials. The volume of wash buffer in trial 2 was kept the same as trial 1. An
elution buffer of 30mM NaOAc pH 5.0 + 450mM NaCl was used in order to elute more VST-
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6700 off the column (Table 1). A total of 4.5BV of this elution buffer was initially used. During
the trial, the elution buffer was changed to 30mM NaOAc pH 5.5 + 500mM because of the poor
elution efficacy of the previous buffer (data not shown). 6BV of this new 30mM NaOAc pH 5.5
+ 500mM elution buffer was used. All flow rates were the maximum allowed by gravity (Table
10). The column was found to retain all 5.6mg of VST-6700 loaded on the column at a pH of 3.
Furthermore, the wash of 30mM sodium citrate pH 3 resulted in no loss of VST-6700 from the
column. Both elution buffers used in trial 2 resulted in a combined peptide recovery of 76.5%.
The low loss of VST-6700 in the load step indicated that more mobile phase could flow through
the resin bed before saturation of analyte. The peptide recovery suggested that an elution buffer
of a higher pH was needed, as high salt concentrations proved unable to elute all VST-6700.
Table 10: Flow rates for equilibration, load, wash, and elution steps of VST-6700 purification on a 2mL SP Sephadex C-25 resin
bed
Trial
Equilibration
(mL/min)
Load (mL/min)

T1
5.45m

T2
5.45m

T3
6.54m

SP Sephadex C-25 Flow Rates
T4
T5
T6
6.15m NRm
8.57m

2.97m

3.51m

2.46m

3.95m

NRm

0.89

Wash (mL/min)

4.74m

3.91m

NRm

5.55m

NRm

Elution
(mL/min)

5.45m

5.45m

6.21m

1.18

5.5(11mL)
1.09(11mL)
1.18 (11mL)
NR (11mL)

1.43
(1.5mL)
6m
1.11

T7
8.39m

T8
8.33m

T9-1
NRm

T9-2
9.11m

T10
NRm

1.5(3mL)
0.90(5mL)
1.48(1.5mL)
5.71(6mL)m

0.83

0.54

0.73

NR

0.91
6.31m

6.32m

6.81m

NRm

1.14

0.76

1.13

NR

NR

Subscript “m” denotes maximum flow rate. NR = not recorded.

In trial 3, the elution buffer was changed to 50mM Tris pH 8.0 based off a previously
developed VST-6700 IEX elution protocol by another researcher. All flow rates were maximum
allowed by gravity. In trial 3, the peptide load mass was nearly doubled, to 9.122mg with a loss
of 1.7% in the load step. No VST-6700 was lost in the wash step. Elution using 4.5 BV 50mM
Tris pH 8.0 at maximum flow rate resulted in a peptide recovery of 78.3%, a marginal increase
from trial 2. This peptide recovery suggested that a restriction of flow rate could increase elution
efficacy of the elution buffer.
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In trial 4, the load mass of VST-6700 was kept the same as trial 3. Equilibration, load,
and wash flow rates were the maximum allowed by gravity; elution flow rate was restricted to
1.18mL/min to allow the elution buffer more time to liberate VST-6700 from the stationary
phase, and thus allow the elution buffer to achieve better elution efficacy on the column. No loss
of VST-6700 in the load or wash step was observed. Restriction of elution flow rate resulted in a
peptide recovery of 86.1%. Twelve BV of elution buffer was used. The results for this trial
indicated that more elution buffer could be used to achieve a higher peptide recovery.
Table 11: Mass balance for VST-6700 on a 2mL SP-Sephadex C-25 resin bed.
SP Sephadex C-25 Mass Balance
Trial
T1
T2
T3
T4
T5
T6
T7
T8
T9-1a
T9-2a T10
VST-6700 Load Mass (mg)
5.603 5.600 9.122 9.135 9.134 ~18 ~18
32
9.494
10.50
20
Mass VST-6700 Lost in Load
2.365
0
0.157
0
0.059 NR NR 0.613 1.432
0.264
NR
(mg)
% Loss in Load
42.2
0
1.7
0
0.6
NR NR
1.9
15.1
2.5
NR
Mass VST-6700 Lost in Wash
0*
0
0
0*
0*
NR NR
0*
0.0658 0.0231 NR
(mg)
% Loss in Wash
0*
0
0
0*
0*
NR NR
0*
0.7
0.2
NR
Mass VST-6700 Retained (mg)
3.237 5.600 8.965 9.135 9.075 NR NR 31.39 8.063
10.23
NR
Mass VST-6700 Recovered (mg) 2.669 4.285 7.022 7.862 7.958 NR NR 24.24 8.343
9.329
0
% Peptide Recovery
82.5
76.5
78.3
86.1
87.7
NR NR
77.2
103.5
91.2
0
All numerical values are calculated from tabulated absorbance and retention data from HPLC analysis. Mass balances for trial 6,
trial 7, and trial 10 were not performed. Percent Yields of elution are based on retained peptide rather than initial VST-6700
loaded. NR = not recorded. * = assumed zero
aAfter

HPLC analysis of the column fractions, it was discovered the Thermo-Fischer UltiMate 3000 UHPLC had a broken
mixing valve, which likely altered the absorbance data obtained by the machine.

In trial 5, equilibration, peptide load, and wash step flow rates were not recorded, but
were the maximum flow rate by gravity. Peptide load was kept the same as trial 4. The elution
flow rate was monitored in a similar manner to trial 4 (Table 10), but more elution buffer flowed
through the column in order to achieve higher peptide recovery. The first 5.5 BV of elution
buffer flowed at a rate of 5.5mL/min due to inadequate control of the stopcock. A total of 22 BV
of elution buffer flowed through the column. The final 5.5 BV of elution flowthrough was not
timed, but flow rate was restricted. No significant loss of VST-6700 was observed in the load
step and wash step. Despite the large amount of elution buffer flowed through the resin bed, a
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peptide recovery of 87.7% was achieved, similar to trial 4, in which much less elution buffer was
used. The results of trial 4 indicated that a stronger elution buffer was needed, and more peptide
could be loaded on the column with minimal peptide loss in the load step.
Due to high peptide retention in trial 5, peptide load was doubled in trial 6 (Table 11).
Load flow rate was restricted to ≤ 1mL/min in order to increase the residence time of VST-6700
on the stationary phase. 50mM of NaCl was added to the 50mM Tris pH 8 buffer in order to
increase elution efficacy on the column. Flow rate for elution step was restricted in order to
maximize elution efficacy of the elution buffer. No mass balance for trial 6 was determined;
changes to the column were determined based off HPLC results (not shown). However, analysis
of peptide presence in the eluate fractions indicated that at least 8 BV of elution buffer was
needed. This observation indicated that adding salt to the elution buffer could provide better
elution efficacy of the elution buffer, and thus use lower volumes to achieve elution of peptide.
In trial 7, the salt concentration in the 50mM Tris pH 8 elution buffer was doubled from
50mM to 100mM in order to elute more VST-6700 from the column. Flow rates for load and
elution were restricted, similar to trial 6. In trial 7, however, mobile phase was allowed to sit in
the stationary phase for approximately 1hr in order to achieve a higher peptide binding. There
was no observed difference in peptide binding between trial 6 and trial 7 (data not shown) based
on analysis of HPLC chromatograms for the presence or absence of peptide. At this point, the
binding capacity of the resin was approximately 9mg VST-6700 per mL of resin. The low
binding capacity of the resin in trial 7 resulted in a different method to load the peptide on the
column in trial 8.
In trial 8, flow rates were controlled in a similar manner to trials 6 and 7. A total of 18mg
of VST-6700 was initially loaded onto the column, and then an additional 2mg of VST-6700 was
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then loaded on the column; each resulting flowthrough was collected and analyzed on HPLC for
presence or absence of VST-6700. This stepwise loading of peptide at a controlled flow rate was
continued for a final load of 32mg of peptide. Based on HPLC results obtained, it was
determined that 20mg of VST-6700 was an optimal load mass for a 2mL SP Sephadex C-25
resin bed. While a 32mg load resulted a 1.9% loss of peptide as determined by mass balance, the
stepwise loading method proved too slow to be optimal. No loss of VST-6700 was observed in
the wash step. Elution buffer was the same as trial 7, and elution with 8.25 BV with a restricted
flow rate resulted in a 77.2% recovery of peptide.
Trial 9 was split into two separate trials due to a mistake; in trial 9-1, the cell-free
fermentation beer was not titrated to pH 3.0 and left at pH 4.8. This mistake was rectified in trial
9-2. In all other aspects, trials 9-1 and 9-2 were performed in the same manner. Load flow rates
and elution flow rates were restricted, while wash and equilibration flow rates were the
maximum allowed by gravity. A total of 20mg of VST-6700 was loaded onto the column, which
was then washed with 3.4 BV of 30mM sodium citrate pH 3. Elution was achieved with 8 BV of
50mM Tris pH 8 +100mM NaCl. Loading beer at a pH of 4.8 was found to result in a weaker
binding of VST-6700 on the column than at pH 3.0, as more mass was lost during the load step
in trial 9-1. There was no significant loss of VST-6700 from the column during the wash step in
trial 9-1 and trial 9-2, and peptide recovery were both above 90% for the trials. However, upon
completion and analysis of the column runs, it was found that the mixing valve on the Thermo
Fisher Ultimate 3000 UHPLC that the fractions were analyzed on had broken. Thus, the mass
balance may not be accurate (see footnote a in Table 11).
In trial 10, the elution reagent was changed to 100% acetonitrile in order to mimic the
elution efficacy of an HPLC gradient to an IEX column. Of 20mg of VST-6700 loaded on the
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column, 100% acetonitrile resulted in elution of no peptide from the column. Flow rates were not
recorded due to time constraints. Mass balances were not performed due to a lack of
chromatograms. Very few HPLC injections of this trial were performed due to time constraint.
Capto S
The initial IEX protocol for trial 1 was provided by another Vestaron researcher. The
equilibration buffer was 30mM NaOAc pH 4.5 and 4 BV were used. Two wash buffers were
used. Four BV of the first wash buffer, 2-(N-morpholino)ethanesulfonic acid (MES, 30mM, pH
6.0) was used and an equal amount of the second wash buffer, MES with added 100mM NaCl,
was used. The elution buffer used in trial 1 was 30mM MES pH 6.0 + 200mM NaCl. The
starting material used in trial 1 was a lower concentration than all other starting materials used
(Table 6). Upon HPLC analysis of the starting material, there were many large peaks from
unknown species (not shown), suggesting many impurities in the beer. The cell-free beer also
clogged filters, making sample preparation difficult. Flow rates were not recorded but were the
maximum flow rate by gravity. Of approximately 1.246mg of VST-6700 loaded on Capto S,
18.9% was lost. In the wash steps with 30mM MES pH 6.0 and 30mM MES pH 6.0 + 100mM
NaCl, nearly 50% of bound peptide was desorbed (Table 13). Elution buffer desorbed 0.010mg
VST-6700 for a peptide recovery of less than 3%. The very low peptide recovery indicated that
the wash buffer needed to be changed in order to reduce the amount of VST-6700 lost in the
wash. Furthermore, the poor starting material needed to be changed to one of higher VST-6700
concentration and less contamination.
In trial 2 the pH of the equilibration buffer was changed from 4.5 to 4.08 in order to
match the pH of new starting material. This should have increased binding of the mobile phase to
the stationary phase. The starting material in trial 2 had a higher concentration of VST-6700 and
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could be filter-sterilized easily. Flow rates were not recorded but were the maximum flow rate by
gravity. The volume of equilibration buffer used was not recorded. 19.593mg of VST-6700 was
loaded onto the column, of which 27.2% was lost. The wash buffer in trial 1 of 30mM MES pH
6.0 + 100mM NaCl was changed to a MES wash buffer with no salt, in order to reduce VST6700 loss during the wash step. Due to a low peptide recovery in trial 1, the elution buffer in trial
2 was changed to 30mM MES pH 6.0 + 100mM NaCl in order to determine optimal NaCl
concentration for elution of VST-6700 from Capto S resin bed. Four BV of both wash and
elution buffer were used. In trial 2, loss of VST-6700 during the wash step was 26.1%. The
peptide recovery in the elution step was 73.5%. The high loss of VST-6700 from the column in
the load step indicated that the stationary phase was oversaturated with analyte and the load mass
needed to be decreased. A high loss of VST-6700 in the wash step suggested that the pH of the
wash buffer needed to be changed. The salt concentration of the elution buffer was increased in
trial 3 due to the low peptide recovery in trial 2.
Table 12: Flow rates for equilibration, load, wash, and elution steps of VST-6700 purification on a 2mL Capto S resin bed.
Capto S Flow Rates
Trial
T1-T8
T9
T10
Equilibration (mL/min)
NRm
2.16m NRm
Load (mL/min)
NRm
NRm NRm
Wash (mL/min)
NRm
NRm NRm
Elution (mL/min)
NRm
NRm NRm
Subscript “m” indicates maximum flow rate by gravity. NR = not recorded.

T11
2.41m
0.81m
1.84m
1.97m

T12
NRm
NRm
NRm
NRm

T13
3.41m
1.25m
2.09m
2.90m

T14
NRm
1.86m
2.33m
3.42m

The VST-6700 load mass in trial 3 was reduced to 8.871mg in order to reduce the loss of
peptide in the load step. The pH of the NaOAc equilibration buffer was changed to 4.5, similar to
trial 1. It was decided that the starting material would be titrated as necessary to the pH of the
equilibrated column in further trials, starting with trial 3. 30mM NaOAc pH 4.5 equilibration
buffer and wash buffer were used until trial 13. Flow rates were not recorded but were the
maximum flow rate by gravity. The volume of equilibration buffer used in trial 3 was not
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recorded. The wash buffer was kept the same as trial 2, and the elution buffer was changed to
30mM MES pH 6.0 + 200mM NaCl in order to elute more analyte from the column. The
volume of wash and elution buffer used in trial 3 was not changed from trial 2. In Trial 3,
adsorbed analyte and peptide recovery could not be accurately calculated due to experimental
error, in which the load void volume was discarded instead of collected. Thus, it was not possible
to obtain an accurate measurement of total peptide bound to the column after the wash step and
the peptide recovery in the elution step. It was upon summation of VST-6700 mass in wash
fractions that 22% loss of total loaded peptide in the wash step was calculated. This result
suggested a wash buffer of different pH was needed.
.

Prior to trial 4, it was learned that starting material was potentially unstable in pH
conditions at 6+. The load mass was reduced to 5.6mg because the last analyzed load fraction
indicated the presence of peptide for that fraction. At that point, no additional VST-6700 was
loaded onto the stationary phase. Flow rates were not recorded but were the maximum flow rate
by gravity. The volume of equilibration buffer used in trial 4 was not recorded. The wash buffer
was changed to 30mM NaOAc pH 4.5 in order to minimize VST-6700 loss in wash fractions; 4
BV was used, with no VST-6700 loss. In trial 4 the elution buffer was changed to 30mM NaOAc
pH 4.5 + 200mM NaCl in order to prevent VST-6700 degradation in higher pH. Eight BV of
elution buffer was used, which resulted in a peptide recovery of 74.5%. The low peptide
recovery indicated that a higher NaCl concentration was necessary in the elution buffer.
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Table 13: Mass balance results for VST-6700 on a 2mL Capto S resin bed.
Capto S Mass Balance
Trial
T1
T2
T3
T4
T5
T7
T8
T9
T11
T13
T14
VST-6700 Load Mass (mg)
1.246 19.593 8.871 5.582 5.709 NR 5.506 5.896 5.543 16.535 11.07
Mass VST-6700 Lost in
0.236 5.321 0.059 0.063 0.077 NR 1.923 1.495 0.332 0.725
0.434
Load (mg)
% Loss in Load
18.9
27.2
0.7
1.1
1.3
NR 34.9
25.4
6.0
4.4
3.9
Mass VST-6700 Lost in
0.634 5.104 1.948
0
0.553 NR
0*
0*
0
0*
0*
Wash (mg)
% Loss in Wash
50.9
26.1
22.0
0
9.7
NR
0*
0*
0
0*
0*
Mass VST-6700 Retained
0.376 9.169
NR
5.519 5.079 NR 3.583 4.401 5.211 15.810 10.634
(mg)
Mass VST-6700 Recovered
0.010 6.737 5.822 4.112 4.761 NR 3.728 4.247 5.435 15.971 11.384
(mg)
% Peptide recovery
2.7
73.5
NR
74.5
93.7 NR 104.1 96.5 104.3 101.0
107.1
All numerical values are calculated from tabulated absorbance and retention data from HPLC analysis. Mass balances for trial 6,
trial 10, and trial 12 are not included (See Tables 14 and 15). NR = not recorded. * = assumed zero

Trial 5 was an attempt to obtain a more accurate mass balance for the column conditions
in trial 3. The trial was conducted because trials 1-3 did not involve the use of void volumes
when changing mobile phases (see IEX Column in Materials and Methods). Thus, the use of
void volumes would result in a more accurate mass balance. Flow rates were not recorded but
were the maximum flow rate by gravity. A total of 5.709mg of VST-6700 was loaded on the
column, with a loss of 1.3%. The buffers in trial 5 were the same as trial 3. The volume of
equilibration buffer used in trial 5 was not recorded. 3.75BV of wash buffer and 5.5 BV of
elution buffer were used. There was a 9.7% loss of loaded VST-6700 in the wash step, however a
93.7% peptide recovery was obtained in elution. A better mass balance for trial 5 supported the
previous results of trials 1-3, in that the MES wash buffer resulted in a high loss of VST-6700
from the column. While the elution buffer in trial 5 proved to be effective, the pH of the elution
buffer was kept lower in trial 6 in order to prevent any potential VST-6700 degradation from
higher pH.
Trial 6 was an attempt to determine an optimal NaCl concentration in the pH 4.5 NaOAc
elution buffer. The volume of equilibration buffer used in trial 6 was not recorded. Load mass of
VST-6700 was 4.94mg. Only the first and last load fractions were analyzed because a 5.709mg
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load mass in trial 5 resulted in less than 2% loss, and so the load loss in trial 6 was assumed to be
near zero. Similarly, the loss of VST-6700 in the wash step was assumed to be zero for trial 6
because trial 4 showed no loss using NaOAc without NaCl. Four buffers for elution were 30mM
NaOAc pH 4.5, with 100mM, 200mM, 350mM, and 500mM NaCl. Two BV wash buffer and
each elution buffer were used. Flow rates were not recorded but were the maximum flow rate by
gravity. The first and last column fractions of each elution buffer were analyzed for the presence
or absence of peptide, and these fractions were analyzed for VST-6700 in the mass balance. Of
the four buffers used, 30mM NaOAc pH 4.5 + 350mM NaCl eluted the most peptide (Table 14),
suggesting that the proper salt concentration for the elution buffer to be used in trial 7 was
around 350mM.
Table 14: Mass Balance of the first and last fractions of each wash and elution buffer flowthrough collected for Capto S trial 6.
Capto S Trial 6 Mass Balance
Mass VST- Mass VSTMass VSTMass VST-6700 Mass VST-6700 Mass VST-6700
6700
6700 lost in
6700 lost in
lost in 100mM
lost in 200mM
lost in 350mM
Loaded
load 1 and
NaOAc Wash salt Wash 1 and salt Wash 1 and salt Wash 1 and
(mg)
5 (mg)
1 and 5 (mg)
4 (mg)
4 (mg)
4 (mg)
4.942
0.012
0.024
0.148
0.865
0.983
The values shown are summations of the mass balance of the first and last fraction for each buffer.

Mass VST-6700
lost in 500mM
salt Wash 1 and
4 (mg)
0.110

In trial 7, the load mass of VST-6700 was kept the same as trial 5 because there was
minimal loss in the load for trial 5. The wash buffer was kept the same as trial 6 because no
significant loss of VST-6700 in the wash occurred. In trial 7, 4BV of wash buffer was used. The
elution buffer was changed to 30mM NaOAc pH 4.5 + 400mM NaCl to increase VST-6700
recovery in elution fractions with NaOAc. Furthermore, 6 BV of elution buffer was used in order
to maximize peptide recovery. Flow rates were not recorded but were the maximum flow rate by
gravity. Mass balance of trial 7 was not recorded due to experimental error in which spillage of
some column fractions occurred. The trial was repeated in trial 8.
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All buffer reagents and volumes were kept the same in trial 8 as trial 7. Flow rates were
not timed but were the maximum flow rate by gravity. Significant loss of VST-6700 occurred in
the load step, nearly 35%. The starting material was significantly more dilute than previous
samples used (Table 6). However, it is not known why such a high loss occurred. Only the first
and last wash fractions were analyzed in trial 8, and the loss of VST-6700 in the wash step is
assumed to be zero because 30mM NaOAc pH 4.5 resulted in no VST-6700 loss in previous
trials. Loss of VST-6700 in the wash step is assumed to be zero for trial 9 as well. A peptide
recovery of 104.1% was obtained, and thus the elution buffer desorbed all analyte from the
stationary phase. The high loss of VST-6700 in the load step resulted in a different loading
method in trial 9.
Table 15: Mass balances of load step for the IEX Purification of VST-6700 on a 2mL Capto S resin bed for trial 10 and trial 12.
Capto S Trial 10 and Trial 12 Mass Balance
Trial
T10
Load
Load 1 Load 2 Load 3 Load 4 Load 1
Mass VST-6700 Loaded (mg) 4.039
4.039
4.039
4.039
5.60
Mass VST-6700 Lost in Load 0.166
0.130
0.145
0.153
0.79
% Loss in Load
4.1
3.2
3.6
3.8
14.1
Average % Loss in Load
3.5

T12
Load 2
5.60
0.68
12.1
13.3

Load 3
5.60
0.76
13.6

The purpose of trial 9 was to starting material onto the column in smaller portions,
resulting in a slower flow rate. Equilibration was timed at the maximum flow rate by gravity,
resulting in an average flow rate of 2.16 mL/min. 5.5BV of buffer was used. It was observed that
the instantaneous flow rate slowed as more equilibration buffer flowed through the stationary
phase. Thus, it was hypothesized that smaller load amounts would result in a slower flow rate
and would increase the residence time of the analyte in the stationary phase, which would
achieve higher binding of analyte to the column. Starting material was loaded in volumes of 1.5
BV, which flowed through the stationary phase until flow stopped. Another 1.5 BV volume of
starting material was then loaded on top of the column. Three total 1.5 BV volumes of starting
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material were loaded, for a total of 5.896mg of VST-6700. Wash buffer, elution buffer, and
volumes were kept the same as trial 8. No flow rates were restricted by closing of the stopcock in
trial 9. The loading method in trial 9 resulted in a VST-6700 load loss of 25.4%, a near 10%
decrease from trial 8. Only the first and last column fractions of the wash step were analyzed,
and thus peptide loss in the wash step is assumed to be zero. Peptide recovery was 96.5%. The
high loss of VST-6700 in the load step resulted in the procurement of a different starting material
of higher VST-6700 concentration in order to limit VST-6700 loss in the load step.
Trial 10 was conducted in order to obtain a quadruplicate set of results for optimal
peptide retention, with the goal of obtaining consistent results. Four column runs were performed
sequentially. Initially a target of 5.6mg of VST-6700 was to be loaded on the column for each
column run. Due to experimental error, only 4.039mg of VST-6700 loaded on the columns. At
the time of Capto S trial 10, it was assumed that the Agilent 1100 was malfunctioning. The
current hypothesis is that the error is probably due to starting material injected into the Agilent
1100 HPLC being too concentrated for accurate peptide measurement, though this was not
hypothesized until Nuvia HR-S trial 7. In trial 10 and in all previous Capto S trials, starting
material was diluted 5x with caffeine and water (see Sample Processing in Materials and
Methods). After the trial 10 was completed, an additional analysis was performed of the starting
material, this one diluted 10x instead of 5x. The concentration of VST-6700 calculated in the
mass balance of the 10x dilution starting material was verified by another Vestaron Researcher.
This new analytical resulted in the determination that only 4.039mg of VST-6700 was initially
loaded on the column. The wash buffer was kept the same as trial 9, and 2 BV was used for each
of the four column runs in trial 10. Elution buffer was also kept the same as trial 9, but the
elution flowthrough was discarded in the four column runs. Mass balance of wash and elution
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fractions was not performed. In Capto S trial 10, all four peptide loads of 4.039mg had less than
5% peptide loss, with an average value of 3.5%. After trial 10 was conducted, it was discovered
that lower salt concentration in elution buffer was optimal, as NaCl could interfere with further
processing of the purified VST-6700. Thus, NaCl concentration in the elution buffer was reduced
in trial 11.
In trial 11 the elution buffer was changed to NaOAc (30mM, pH 5.0 + 300mM NaCl) in
order to minimize the amount of NaCl necessary for the elution of VST-6700 from Capto S.
Elution buffer pH was increased to 5.0 in order to achieve a similar elution efficacy as the elution
buffer in trials 7-10. Equilibration buffer, VST-6700 load mass, and wash buffer were kept the
same as trial 7-9. Six BV of equilibration buffer was used and 3.75 BV of wash buffer was used.
Flow rates were recorded (Table 12) and were the maximum flow rate by gravity. VST-6700
load loss was 6% and peptide loss in the wash step was assumed to be zero. The pH increase and
NaCl decrease in the elution buffer resulted in a peptide recovery of 104.3%, which suggests that
all bound peptide was desorbed from the stationary phase.
Trial 12 was an attempt to obtain a precise set of triplicate data for VST-6700 retention.
The purpose of the trial was to obtain load loss results using the buffers of trial 10, and to obtain
a more accurate mass balance than trial 10. Column fraction samples were analyzed in the
Thermo Fisher Ultimate 3000 UHPLC in trial 12 instead of the Agilent 1100 Series due to
suspected Agilent 1100 malfunction. Equilibration, wash, and elution buffer were kept the same
as trial 10. Six BV of equilibration buffer, 3.75 BV of wash buffer, and 6 BV of elution buffer
were used in trial 12. All flow rates were maximum by gravity. All thee peptide loads of 5.60mg
had a less than 88% peptide retention (Table 15). No loss of VST-6700 was observed in the
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wash step. Elution flowthrough was discarded. The results from trial 12 indicated that column
pH should be changed in order to increase binding capacity of Capto S.
The equilibration buffer used in trial 13 was changed to 30mM sodium citrate pH 3.0 in
order to improve loading capacity of VST-6700 on the 2mL Capto S resin bed. Initially, 10mg of
VST-6700 was loaded on the column, and the resulting flowthrough was analyzed in HPLC for
presence or absence of peptide. A total of 2mg was then sequentially loaded and analyzed in
HPLC until a final load mass of 16.5mg. Stationary phase and starting material pH were changed
to pH 3.0 based off optimized SP Sephadex C-25 trial 9 protocol. The wash buffer was also
changed to 30mM sodium citrate pH 3.0 based off optimized SP Sephadex C-25 trial 9 protocol.
Six BV of equilibration buffer, 4 BV of wash buffer, and 7 BV of elution buffer were used.
Elution buffer was kept the same as trial 11. An equilibration, load, and wash at pH 3 with
30mM sodium citrate resulted in nearly tripling the peptide load to 16.5mg with a greater than
95% peptide retention during loading and no loss of VST-6700 in the wash step. However, the
stepwise manner of loading was much slower than previous loading methods. Analysis of HPLC
chromatograms for peptide presence or absence determined that the optimal peptide load on
Capto S at pH 3.0 was approximately 11mg. Other Vestaron researchers scaled-up the SP
Sephadex C-25 IEX protocol and determined that 30mM Tris pH 8.8 was optimal in elution of
VST-6700 from the stationary phase. This buffer was tested in trial 14.
In trial 14, the elution buffer was changed to 30mM Tris pH 8.8 in order to minimize the
amount of NaCl necessary to elute VST-6700 from Capto S. Equilibration of the stationary phase
with 6 BV of 30mM citrate pH 3 was performed. A peptide load of 11.07mg on an equilibrated
column at pH 3 resulted in VST-6700 retention of 96.1%. Only the first wash fraction was
analyzed in the HPLC. VST-6700 loss in the wash step after 4 BV of wash buffer was assumed
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zero because 30mM sodium citrate pH 3.0 resulted in no VST-6700 loss in the wash step of trial
13. Elution buffer of 30mM Tris pH 8.8 resulted in elution of all adsorbed peptide from the
column. Seven BV of elution buffer was used. All flow rates were maximum by gravity.
Nuvia HR-S
The volume of resin bed in Nuvia HR-S trials 1-6 was 2.25mL. The equilibration buffer
used in trial 1 was 30mM NaOAc pH 4.5 based off Capto S trial 8. A total of 5.33 BV of
equilibration was used. 30mM NaOAc pH 4.5 equilibration buffer was used for Nuvia HR-S
trials 1-6. The wash buffer of 30mM NaOAc pH 4.5 and elution buffer of 30mM NaOAc pH 4.5
+ 400mM NaCl were used based of Capto S trial 8 which indicated no peptide loss during the
wash step and ~100% peptide recovery during the elution step. All flow rates for Nuvia HR-S
were the maximum flow rate by gravity. Flow rates in trial 1 were not recorded. A total of
11.34mg of VST-6700 was loaded on the 2.25mL Nuvia HR-S resin bed, with a resulting peptide
loss of less than 1%. Use of 3.6 BV of wash buffer resulted in no loss of VST-6700 during the
wash step, and 4 BV of elution buffer resulted in a 68% mass recovery of adsorbed analyte on
the Nuvia HR-S stationary phase (Table 17). The very low load loss in trial 1 suggested that
more mobile phase could be introduced to the stationary phase and achieve higher binding of
peptide. The low mass recovery indicated that the elution buffer pH or salt concentration needed
to increase. Furthermore, there were numerous smaller peaks near the VST-6700 peak in the
elution fraction chromatograms (not shown), suggesting that added salt to the wash buffer could
better remove impurities from the stationary phase.
The concentration of the VST-6700 starting material was not validated before trial 2. A
concentration of 2.30mg/mL VST-6700 was provided by another Vestaron researcher. Intended
load mass for trial 2 was 20mg. Starting material was analyzed along with column fractions at
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the end of the column run. The concentration of VST-6700 in the starting material was calculated
to be 2.9mg/mL resulting in a load mass being calculated to be 24.75mg. In trial 2, 50mM NaCl
was added to the NaOAc wash buffer in order to better remove impurities from the starting
material. Four BV was used. In trial 2 the elution buffer was changed to was 30mM NaOAc pH
5.0 + 450mM NaCl in order to increase elution of VST-6700 from the Nuvia HR-S resin bed.
During elution, 5.33 BV of elution buffer was used. Flow rates for trial 2 were not recorded but
were the maximum flow rates allowed by gravity. A total of 24.75mg of VST-6700 was loaded
onto the stationary phase with a measured 93.6% retention of analyte during loading. Adding salt
to the wash buffer resulted in 6.4% loss of VST-6700. A 133.8% peptide recovery was calculated
by HPLC mass balance (see footnote a in Table 17). At the time of the trial, it was thought that
the Agilent 1100 Series had malfunctioned and incorrectly analyzed the starting material and
elution fractions, resulting in an inaccurate mass balance.
In trial 3 the elution buffer was changed to 30mM NaOAc pH 5.0 + 400mM NaCl in
order to minimize the concentration of NaCl required to elute VST-6700 off the column
effectively. In trial 3 only the equilibration flow rate was recorded (Table 16). The volume of
equilibration buffer used was not recorded. Load, wash, and elution flow rates were not recorded
but were the maximum flow rate by gravity. A total of 3.6 BV of wash buffer was used. In trial
3, the goal was to load 20mg of VST-6700 onto the stationary phase. Based on starting material
concentration provided by another researcher, 8.5mL starting material was loaded for an
intended peptide load of 20mg. Starting material was analyzed along with column fractions at the
end of the column run. The concentration of VST-6700 starting material was calculated as 3.26
mg/mL. The load mass was then revised to be 27.72mg instead of 20mg. Approximately 5.5% of
loaded VST-6700 was lost in the wash step, leaving 24.072mg VST-6700 on the column (Table
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17). Elution with 5.33 BV of 30mM NaOAc pH 5.0 + 450mM NaCl resulted in elution of all
bound analyte from the stationary phase. At the time of the trial it was believed that the Agilent
1100 Series had malfunctioned and incorrectly analyzed the samples for the trial 3. For Nuvia
HR-S trials 4-6, all fractions were analyzed on the Thermo-Fisher Ultimate 3000 UHPLC,
because analysis of starting material on the UHPLC resulted in comparable mass balances to
another Vestaron researcher.
The VST-6700 load in trial 4 was reduced to 23mg in order to maximize peptide load.
The concentration of VST-6700 in the starting material mass balance was determined to be
2.84mg/mL, therefore 8.1mL of starting material was loaded. Upon completion of the trial, it
was discovered that the Thermo-Fisher Ultimate 3000 UHPLC integrated the peaks for the
starting material in a drop perpendicular integration (Fig. 3). Valley-to-valley integration was
previously used for all samples. This issue was fixed upon manual valley-to-valley integration
and it was determined that the concentration was 2.42mg/mL; thus, 19.6mg VST-6700 was
actually loaded on the stationary phase. This load resulted in 5.5% loss in the load step, less loss
than trial 3. The NaCl concentration in the wash buffer was doubled to 100mM in order to better
wash off impurities from the stationary phase. A total of 3.2 BV of wash buffer was flowed
through the stationary phase with a loss of 11.8% peptide during in the wash step. In trial 4, the
elution buffer was changed to 30mM NaOAc pH 5.0 + 400mM NaCl in order to reduce the
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amount of NaCl needed in the elution buffer. After 4.8 BV of elution buffer, a peptide recovery
of 100.4%

Figure 3: Chromatogram for VST-6700 starting material, Nuvia HR-S trial 4. Typically, valley-to-valley integration was used for
all samples. For this trial, integration was drop perpendicular which resulted in an overestimation of peptide.

of bound analyte was calculated. All flow rates were the maximum flow rate by gravity The
results of trial 4 suggested that less NaCl could be used in the elution buffer to achieve a high
mass recovery. The high load loss indicated that the Nuvia HR-S stationary phase was
oversaturated with analyte and that a smaller load was needed. The high loss of VST-6700 in the
wash step indicated that the salt concentration in the wash buffer was too high and needed to be
reduced.
Table 16: Flow rates for equilibration, load, wash, and elution steps of VST-6700 purification on a 2mL Nuvia HR-S resin bed.
Nuvia HR-S Flow Rates
Trial
T1
T2
T3
T4
Equilibration (mL/min) NRm NRm 0.748m 1.09m
Load (mL/min)
NRm NRm
NRm
0.54m
Wash (mL/min)
NRm NRm
NRm
0.73m
Elution (mL/min)
NRm NRm
NRm
0.73m
Subscript “m” indicates maximum flow rates. NR = not recorded.

T5
1.04m
0.63m
0.72m
0.91m

T6
1.21m
0.60m
NRm
0.97m

T7
1.523m
0.77m
0.69m
1.08m

T8
NRm
0.68m
0.78m
1.12m

In trial 5 the load mass of VST-6700 was reduced to 18mg, which resulted in a 2.8% loss
in the load step. A total of 5.33 BV of equilibration buffer was used. NaCl concentration in the
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NaOAc wash buffer was reduced to 50mM in order to reduce the loss of VST-6700 in the wash
step. After 3.2 BV of wash buffer passed through the stationary phase, a VST-6700 loss of 4.9%
was calculated. The elution buffer was changed to 30mM NaOAc pH 5.0 + 200mN NaCl in
order to reduce the concentration of NaCl needed to achieve high elution efficacy. This buffer
resulted in a ~13% mass recovery of bound analyte after 4.8 BV was used. Increasing the
concentration of NaCl to 300mM in the same trial resulted in elution of 78.6% of adsorbed
analyte after 3.2 BV, for a total mass recovery of 92.3%. All flow rates were the maximum flow
rate by gravity. 30mM NaOAc pH 5.0 + 300mM NaCl was proposed in trial 6 to improve elution
efficacy compared to 30mM NaOAc pH 5.0 + 200mM NaCl.
Table 17: Mass balance of HPLC absorption data of VST-6700 IEX purification on a 2mL Nuvia HR-S resin bed.

Trial
VST-6700 Load Mass (mg)
Mass VST-6700 Lost in Load (mg)
% Peptide Loss in Load
Mass VST-6700 lost in Wash (mg)
% Peptide Loss in Wash
Mass VST-6700 Retained (mg)

Nuvia HR-S Mass Balance
T1
T2a
T3a
T4
11.341 24.75 27.716 19.617
0.025 1.581 2.293
1.073
0.2
6.4
8.3
5.5
0
1.579 1.351
2.322
0
6.4
4.9
11.8
11.32 21.59 24.07
16.22

T5
T6
T7
T8
18.15
18.15 32.0 31.622
0.63
0.50 0.122 0.972
3.5
2.8
0.4
3.1
0.89
0.79 0.163
0
4.9
4.3
0.5
0
16.62
16.86 31.72 30.65
2.28
Mass VST-6700 Recovered (mg)
7.775 28.89 24.34
16.28
13.07
15.83 29.85 32.35
15.35 (tot.)
13.7
% Peptide Recovery
68.7
133.8 101.1
100.4
78.6.
93.9
94.1
105.6
92.3 (tot.)
aIn Trial 2 and 3, it was found that the samples ran in the HPLC had a larger absorbance than was typical, resulting in inaccurate
mass balances. It was previously thought that the Agilent 1100 was malfunctioning. The samples may have been outside the LDR
for the Agilent 1100 Series due to a 5x dilution for the samples, resulting in error. This was not hypothesized until Nuvia HR-S
trial 7. Trials 4-7 were analyzed in the Thermo-Fisher Ultimate 3000 in order to obtain accurate mass balances. In trial 7 and 8,
starting material, wash, and load fractions were diluted 10x. Elution fractions were diluted 20x.

In trial 6, 5.33 BV of 30mM NaOAc pH 4.5 equilibration buffer was used. The VST6700 load mass was kept the same as trial 5. The wash buffer and volume of wash buffer used
was kept constant to trial 5. Elution buffer used was 30mM NaOAc pH 5.0 + 300mM NaCl in
order to optimize the NaCl concentration in the elution buffer. In trial 6, all flow rates were the
maximum flow rate by gravity. The wash flowthrough was not recorded. Using 3.2 BV of wash
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buffer resulted in a VST-6700 loss of 4.3%. Using 5.33 BV 30mM NaOAc pH 5.0 + 300mM
NaCl elution buffer resulted in a peptide recovery of 93.9%.
In trial 7, for HPLC analysis all fractions were diluted 10x rather than 5x in an attempt to
stay within the limit of linearity in the Agilent 1100 Series and the Thermo-Fisher Ultimate
3000. Equilibration buffer was changed to 30mM sodium citrate pH 3.0 in order to load more
VST-6700 on a 2mL Nuvia HR-S resin bed. A total of 8 BV of equilibration buffer was used.
Wash buffer was changed to 30mM sodium citrate pH 3.0 + 50mM NaCl in order to maintain a
pH of 3.0 while still washing impurities from the stationary phase, and 4BV was used. The
equilibration was chosen based on SP Sephadex C-25 trial 9, in which a column at pH 3.0
allowed the stationary phase to achieve a higher binding capacity for VST-6700. Elution buffer
was kept constant to trial 6. Initially, 20mg of VST-6700 was loaded and the resulting
flowthrough analyzed by HPLC for presence or absence of peptide. A total of 2mg of VST-6700
was then sequentially loaded and analyzed in HPLC until a final load mass of 32mg was
obtained. There was a total peptide loss of 0.3% in the load step. A total of 8.88 BV of elution
buffer was used with a corresponding peptide recovery of 94.1%. The results of trial 7 suggested
that a pH gradient may improve mass recovery of bound analyte, and that elimination of NaCl
from the wash buffer could result in less loss of VST-6700 in the wash step.
In trial 8, the VST-6700 load was kept the same as trial 7, but 32mg was loaded at once,
rather than in a stepwise method. This resulted in a peptide loss of 3.1% during the load step.
The elution buffer was changed to 30mM Tris pH 8.8 in order to minimize the amount of NaCl
necessary to elute VST-6700 from Nuvia HR-S. During elution, 8 BV was used. Equilibration
buffer was the same as trial 7. Equilibration volume and flow rate was not recorded. All flow
rates were the maximum by gravity. Wash buffer and volume used was kept the same as trial 7.
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There was no loss of VST-6700 in the wash step. In trial 8, the column was pre-equilibrated the
day before the trial was conducted. In trial 8, the elution buffer of 30mM Tris pH 8.8 resulted in
a peptide recovery of 105.6%, suggesting that all analyte was desorbed from the stationary
phase.

Macro-Prep CM
The equilibration buffer used in trial 1 was 30mM sodium citrate pH 3 based on SP
Sephadex C-25 trial 9, Capto S trial 14, and Nuvia HR-S trial 8. These trials found that column
conditions of pH 3 resulted in the highest analyte adsorption to the stationary phase. Seven BV
of equilibration buffer was used. The wash buffer used in trial 1 was 30mM sodium citrate pH
3.0 + 50mM NaCl based on Nuvia HR-S trial 7. This buffer had been found to remove impurities
left on the stationary phase from the mobile phase after loading. A total of 4 BV of wash buffer
was used. The elution buffer was 30mM Tris pH 8.8 based on Nuvia HR-S trial 8 results
indicating a peptide recovery of above 90%. In trial 1, all flow rates were the maximum flow rate
allowed by gravity (Table 18), based off previously optimized Nuvia HR-S and Capto S results.
Due to high peptide retention in Nuvia HR-S trial 8, a VST-6700 load mass of 32mg was chosen.
Of the 32mg VST-6700 loaded on Macro-Prep CM at pH of 3.0, 30.175mg passed through the
column during the load and wash steps for a total peptide loss of 94.2%. Of the 1.844mg VST6700 still bound to the stationary phase, 0.179mg was desorbed in the elution phase after 10 BV
for a peptide recovery of 9.7%. The results of trial 1 suggested that flow rates for the load, wash,
and elution phases needed to be restricted to less than 1 mL/min, similar to SP Sephadex C-25.
Further, overall load needed to be reduced.
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Table 18: Flow rates for equilibration, load, wash, and elution phases of VST-6700 purification on a 2mL Macro-Prep CM resin
bed.
Macro-Prep CM Flow Rates
Trial
T1
T2
T3
Equilibration (mL/min) NRm 1.704m
1.57m
Load (mL/min)
1.19m
0.84
0.51
0.49(1.34mL)
Wash (mL/min)
1.01m
0.76
1.13 (6.66mL)m
Elution (mL/min)
1.82m
0.90
1.29
Subscript “m” denotes maximum flow rate by gravity. NR = not recorded.

T4
1.60m
0.48
0.46(1.5mL)
NRm
0.73

Seven BV of the equilibration buffer used in trial 1 was used in trial 2. In trial 2, NaCl
was eliminated from the Tris wash buffer in order to minimize VST-6700 loss in the wash. A
total of 4 BV of the wash buffer was used. The elution buffer was kept the same as trial 1. In trial
2, the load and wash flow rates were restricted to minimize VST-6700 loss. The elution flow rate
was also restricted to improve 30mM Tris pH 8.8 elution efficacy. The VST-6700 load mass was
reduced to 5mg in trial 2, with a 12% peptide loss. During the wash step, 2.678mg of VST-6700
was lost resulting in a 53% peptide loss (Table 19). No peptide was pulled off in the elution
phase after 10 BV of elution buffer at restricted flow rate. The high analyte loss from the
stationary phase during the load and wash indicated that different buffer and pH conditions were
needed on the column. The poor elution efficacy of the 30mM Tris pH 8.8 buffer suggested that
a pH gradient was not sufficient to elute the bound analyte from the stationary phase.
Table 19: Mass balance of VST-6700 IEX purification on a 2mL Macro-Prep CM resin bed.
Macro-Prep CM Mass Balance
Trial
T1
T2
VST-6700 Load Mass (mg)
32.02 4.991
Mass VST-6700 lost in load (mg) 22.78 0.613
% Load Loss
71.1
12.3
Mass VST-6700 lost in wash (mg) 7.40 2.678
% Loss from wash
23.1
53.7
Mass VST-6700 Retained (mg)
1.844
1.7
Mass VST-6700 Recovered (mg) 0.179
0
% Peptide recovery
9.7
0
All values were calculated from HPLC absorbacnce values.

T3
9.997
0.259
2.6
0
0
9.737
7.293
74.9

T4
9.315
0.332
3.6
0
0
8.983
7.072
78.7

In trial 3 the equilibration buffer was changed to 30mM 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) pH 7.0 in order to increase VST-6700 loading on the

OPTIMIZATION OF CATION EXCHANGE

39

2mL Macro-Prep CM resin bed. The wash buffer in trial 3 was changed to 30mM HEPES pH 7
in order to minimize VST-6700 loss with the equilibration buffer and starting material pH
change. HEPES was chosen based off an IEX purification procedure from Staby et al. and Calik
et al. [3,14]. In trial 3, elution buffer was changed to 30mM HEPES pH 7 + 500mM NaCl in
order to elute more VST-6700 from the Macro-Prep CM stationary phase. The VST-6700
loading mass was changed to 10mg in order to determine the binding capacity of the stationary
phase at pH 7. Flow rates were restricted as in a similar manner as trial 2. In trial 3, column
conditions of pH 7 with HEPES (Table 4) resulted in a peptide loss of 2.6. No loss of VST-6700
was observed in the wash phase after 4 BV of wash buffer. Elution buffer of 500mM NaCl
resulted in a 74.9% peptide recovery after 8 BV. The low load loss in trial 3 suggested that 10mg
was an acceptable load mass of VST-6700 on the column at column pH of 7. The low peptide
recovery in the elution phase indicated that the elution buffer needed to be changed.
The equilibration buffer, wash buffer, and VST-6700 load mass in trial 4 were kept the
same as trial 3. Nine BV of equilibration buffer and 4 BV of wash buffer were used. The elution
buffer in trial 4 was changed to 30mM HEPES pH ~ pI, + 500mM NaCl in order to create a net
charge of zero on the VST-6700 molecule, which should allow the elution buffer to achieve a
higher elution efficacy. Flow rates were restricted as in trial 2 and 3. In trial 4 a similar peptide
load of 10mg had a 3.6% loss in the load phase. No loss of VST-6700 was observed in the wash
phase. A 78.8% peptide recovery was determined after 8 BV of elution buffer for trial 4, a small
increase from trial 3.
Discussion
All optimized resins show different load capacities, recoveries, and process times. For SP
Sephadex C-25, the max peptide load was 20mg. Using a pH gradient from 3.0 to 8.0 and a NaCl
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gradient from 0 to 100mM (Table 20) resulted in a peptide recovery of 77%. The optimized
process time for SP-Sephadex C-25 is approximately 20 minutes for a 2mL resin bed volume,
excluding cleaning and re-equilibration of columns. Process times were determined using flow
rates and buffer volumes for equilibration, load, wash, and elution steps.
Capto S had a maximum load capacity of 11mg. Using a pH gradient from 3.0 to 8.8
during elution corresponded to a 100% recovery of retained peptide. Capto S had the fastest
process time of all resins tested, at approximately 13 minutes for a 2mL resin bed. This is due to
being able to use maximum flow rates by gravity.
Table 20: Optimal conditions and process times for the four resins evaluated in this project.

Equilibration
Buffer

Wash
Buffer

Elution
Buffer

Est.
Recovery

Est. Process
Time per mL
resin
(min:sec)

Est. Process
Time per mg
loaded VST6700 (min:sec)

20

30mM Citrate,
pH 3.0 (6 BV)

30mM
Citrate,
pH 3.0
(3.4 BV)

50mM Tris,
pH 8.0 +
100mM
NaCl
(8 BV)

77%

9:37

0:58

Capto S

11.07

30mM Citrate,
pH 3.0
(6 BV)

30mM Tris,
pH 8.8
(7 BV)

100%

6:40

1:12

Nuvia HRS

32.0

30mM Citrate,
pH 3.0
(8 BV)

30mM Tris,
pH 8.8
(8 BV)

100%

25:37

1:36

Resin

SP
Sephadex
C-25

Load
Capacity
(mg)

30mM
Citrate,
pH 3.0
(4 BV)
30mM
Citrate,
pH 3.0
(4 BV)

30mM
HEPES, pH
30mM HEPES,
Macro~pI +
9.315
pH 7
78%
23:37
5:04
Prep CM
500mM
(9 BV)
NaCl
( 8 BV)
All bed volumes were a volume of 2mL in optimized IEX protocols for all resins. Bed volumes for VST-6700 load depend on
starting material concentration.
30mM
HEPES,
pH 7
(4 BV)

Nuvia HR-S had the slowest process times, at ~50 minutes per BV of resin. The slow
process time for Nuvia HR-S could be because of the small particle size of the resin. Inversely,
Nuvia HR-S had the highest load capacity at 32mg VST-6700. The pH gradient from 3.0 to 8.8
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corresponds to a peptide recovery of 100% retained analyte. Maximum flow rates by gravity
were used in all trials of Nuvia HR-S.
Macro-Prep CM had a maximum VST-6700 load of 9.3mg using 30mM HEPES pH 7. A
combination of a pH gradient and NaCl gradient was used. The pH gradient was from 7 to VSTVST-6700 pI, and the NaCl gradient was from 0 to 500mM. The combination of these two
gradients during elution corresponded to a peptide recovery of 78%. Process times for MacroPrep CM are slower than Capto S and SP Sephadex C-25, at 47 minutes per BV of resin.
Conclusion
Ion exchange chromatography is a common chemical separation technique and the theory
and kinetics of ion exchange are well-characterized. In this study, resins were optimized on a
trial-by-trial basis. The purpose of the study was initially to optimize and evaluate a commercial
IEX cation exchange resin for the replacement of SP Sephadex C-25 for the purification of VST6700. However, the project was not completed by the time scale-up was required. Thus, it was
determined that SP Sephadex C-25 resin was the best resin available for Vestaron, and the resin
optimization presented in the current study was performed for the scale-up. Optimized protocols
of Capto S, Nuvia HR-S, and Macro-Prep CM will be compared to the optimized protocol of SP
Sephadex C-25 for future purification projects.
While SP Sephadex C-25 was the best resin for Vestaron for scale-up, Capto S is the best
resin to replace SP Sephadex C-25 for VST-6700 purification. While SP Sephadex C-25 and
Nuvia HR-S were found to load more VST-6700 than Capto S, the faster process times of Capto
S (due to maximum flow rates by gravity) makes Capto S a more efficient IEX resin for VST-
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6700 purification. Furthermore, the elution buffer used in Capto S elutes all VST-6700 from the
stationary phase which results in a higher peptide recovery than SP-Sephadex C-25.
Capto S has sulfonate binding ligands attached to dextran extenders. While the exact
structure of Capto S is proprietary to GE Healthcare, it is possible that this structure may
contribute to the binding affinity of VST-6700 on Capto S. The presence of dextran extenders
may affect how proteins interact with the agarose matrix of Capto S [7,15]. A slower flow rate
may have allowed a larger peptide load on the 2mL resin bed [7], but it must be stressed that the
proteins themselves dictate much of the interaction between analyte and stationary phase.
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